CME/CE articles from PAINWeek


myCME is pleased to announce its partnership with PAINWeek!

Our combined mission is to produce and deliver timely, clinically relevant, independent, and innovative CME that helps clinicians improve the quality of patient care, through content that is well-balanced, scientifically rigorous, objective, and evidence-based.

Please see below for the activities that will provide you clinical information on pain management. Please click here to visit the PAINWeek website for additional activities on pain management.

CME/CE articles from PAINWeek 2012


myCME is pleased to announce its partnership with PAINWeek!

Our combined mission is to produce and deliver timely, clinically relevant, independent, and innovative CME that helps clinicians improve the quality of patient care, through content that is well-balanced, scientifically rigorous, objective, and evidence-based.

Please see below for the activities that will provide you clinical information on pain management. Please click here to visit the PAINWeek website for additional activities on pain management.




NEW DRUG CME FROM MPR

New Drug Approvals

     
    Exclusively from myCME.com and the editors of MPR
     
  • Learn about the newest drug approvals and uses while earning CME/CE credit

CME Webcast Series


Two red-hot topics for primary care clinicians, presented by the Johns Hopkins University School of Medicine. The first educates clinicians on the significant challenges in revising the National Cholesterol Education Program Adult Treatment Panel guidelines and provides balanced recommendations. The second educates primary care clinicians on the evidence-based treatment of heart failure and provides guidance for commonly encountered clinical dilemmas.

Click here for more information on the series.


Breakthrough Cancer Pain Monographs

Breakthrough cancer pain (BTCP) is a common occurrence in cancer patients that can be treated by a number of immediate-release (IR) opioids, some of which are specifically labeled for this use (i.e., IR fentanyl). However, the predominant use of breakthrough pain products, particularly the IR fentanyls, is off-label for noncancer pain-related diagnoses. Education is needed around the safe use of opioid analgesics and, more specifically, the IR fentanyl medications for BTCP. This educational program is specifically designed to support this objective.

Click here for a full listing of activities.

Case Clinics


myCME Case Clinics consist of integrated accredited case studies focused on various therapeutic areas of interest. These are brief CME or CE activities offering from 0.25 to .50 credit hours. Click here to see current activities.

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


is free, fast, and customized just for you!

Already a member?

Sign In Now »